|
WHAT'S THIS?
|
Home
About us
Email sign up
Basics
Commentary
- General
- Best practice
- Clinical trial registries
- Selective publication
- Industry payments
Viewpoints
Press releases
Resources
Directory
|
|
|
|
|
|
This is a freely accessible online resource for everyone involved in publication planning. Help us build the site into a valuable resource for, amongst others, medical writers and communications professionals, pharmaceutical industry managers, medical journal editors and publishers.
Please send your ideas, contributions and comments about the articles to the Editor of The Publication Plan, Mary Greenacre.
If you have any other comments about the service, the web site, or questions about advertising and sponsorship, please contact the Publisher, Peter Llewellyn.
|
|
|
Related Sites
|
|
COMMENTARY
|
This section collates links to previously published articles and news stories. In the near future, we will be bringing you Feature Articles specially written for ThePublicationPlan.com by experts in the field.
The five latest additions are highlighted below, the rest can be found via the menu on the left.
|
|
|
FEATURE ARTICLE for ThePublicationPlan.com – Impact of legislation and reporting standards on publication planning
Published 11 November 2008
The publication planning landscape has changed dramatically over the past 10 years. We have moved from an arena largely free of restriction and regulation to one that has come under intense and sustained scrutiny from several sources – legislators, journal editors, medical societies, commentators and even mainstream newspapers. Today, many Pharma companies have publication policies and procedures in place to routinely register clinical trial protocols, and some have ensured that summaries of past trial results (published or not) are publicly available on their own registries.
[Access full article here].
|
|
|
Improving the reporting of pragmatic trials: an extension of the CONSORT statement
Published 11 November 2008
A pragmatic trial is broadly defined as a randomised controlled trial whose purpose is to inform decisions about practice. The BMJ reports an extension of the CONSORT statement which is intended to improve reporting of pragmatic trials, focusing on helping practitioners to decide how applicable the trial is to their own practice.
[Link to original source material]
|
|
|
Updated Estimates of Pharmaceutical Company Payments to Physicians in Vermont
Published 5 November 2008
More from JAMA on pharma company payments.
[Link to original source material]
|
|
|
GlaxoSmithKline to limit payments it makes to US doctors to $150,000 a year
Published 30 October 2008
More from the BMJ on industry payments to doctors.
[Link to original source material]
|
|
|
Research methods and reporting
Published 22 October 2008
This article introduces a new section in the BMJ that will contain 'how to' articles on doing and writing up research. Articles for the new section should propose and explain practical and theoretical developments in research.
[Link to original source material]
|
|
WHAT ELSE?
|
Early each month we send out a short email newsletter featuring the latest news and articles.
Sign up here.
|
|
|
PUBLICATION STRATEGY & PLANNING WINTER SCHOOL
28-30 January 2009
Led by Liz Wager
Organized by Management Forum
View details here
|
|
|
|
How to Publish in BioMedicine: 500 tips for success.
Written by Jane Fraser. 2nd Edition published April 2008r
This bestselling guide is highly recommended for all professionals and students in biomedical disciplines, including doctors, PhD and post-doctorate students, lecturers and researchers in medicine, physiology, biochemistry, molecular biology and pharmacology. It is also offers vital guidance for researchers in pharmaceutical, biotech and medical device companies, including veterinary, agricultural and medical sectors. Professional writers and editors will also find it enlightening.
View details here
|
|
|
